Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Journal Information Boards and committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

APC

Authors Guide Submit Manuscript

Crossref

1. Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma

- Stijn Van Hees

- Peter Michielsen

- Thomas Vanwolleghem

2. The role of PIVKA-II in hepatocellular carcinoma surveillance in an Asian population

- Wai-Yoong Ng

- Daniel Yan-Zheng Lim

- Si-Yu Tan

- Jason Pik-Eu Chang

- Thinesh Lee Krishnamoorthy

- Chee-Hooi Lim

- Damien Meng-Yew Tan

- Victoria Sze-Min Ekstrom

- George Boon-Bee Goh

- Mark Chang-Chuen Cheah

- Rajneesh Kumar

- Chin-Pin Yeo

- Chee-Kiat Tan

3. A Novel LC‐MS/MS Assay for Quantification of Des‐carboxy Prothrombin and Characterization of Warfarin‐Induced Changes

- Abdul Basit

- Bhagwat Prasad

- Joanne K. Estergreen

- Daniel E. Sabath

- Nathan Alade

- David L. Veenstra

- Allan E. Rettie

- Kenneth E. Thummel

4. Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis

- Gian Paolo Caviglia

- Davide Giuseppe Ribaldone

- Maria Lorena Abate

- Alessia Ciancio

- Rinaldo Pellicano

- Antonina Smedile

- Giorgio Maria Saracco

5. Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysis

- Hao Xing

- Yi-Jie Zheng

- Jun Han

- Han Zhang

- Zhen-Li Li

- Wan-Yee Lau

- Feng Shen

- Tian Yang

6. A novel model based on interleukin 6 and insulin-like growth factor II for detection of hepatocellular carcinoma associated with hepatitis C virus

- Mohamed M. Omran

- Sara Mosaad

- Tarek M. Emran

- Fathy M. Eltaweel

- Khaled Farid

7. New Thresholds for AFP and Des-γ-Carboxy Prothrombin in Chronic Liver Disease Depending on the Use of Nucleoside Analogs and an Integrated Nomogram

- Ting Sun

- Ruicen Li

- Yiwen Qiu

- Shu Shen

- Wentao Wang

8. Combining serologic biomarkers with the PAGE B score improves risk stratification for hepatocellular carcinoma development among chronic hepatitis B patients

- Michael Stec

- Mark Anderson

- Mary A. Rodgers

- Tiffany Fortney

- Danny Ka-Ho Wong

- Lung-Yi Mak

- Man-Fung Yuen

- Gavin A. Cloherty

9. Efficacy of PIVKA-II in prediction and early detection of hepatocellular carcinoma: a nested case-control study in Chinese patients

- Rentao Yu

- Xiaomei Xiang

- Zhaoxia Tan

- Yi Zhou

- Haoliang Wang

- Guohong Deng

10. Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation study

- Huaping Chen

- Siyuan Chen

- Shan Li

- Zhijian Chen

- Xuan Zhu

- Meiyu Dai

- Lingxi Kong

- Xiaodan Lv

- Zhili Huang

- Xue Qin

11. Evaluation of the diagnostic accuracy of des-gamma-carboxy prothrombin and alpha-fetoprotein alone or in combination for hepatocellular carcinoma: A systematic review and meta-analysis

- Jia Fan

- Yu Chen

- Dan Zhang

- Juan Yao

- Zijun Zhao

- Yao Jiang

- Yiqin Li

- Yongcan Guo

12. Diagnostic value of TAP, PIVKA-II, and AFP in hepatocellular carcinoma and their prognostic value for patients treated with transarterial chemoembolization

- Delu Gan

- Yali Wang

- Xin Yang

- Juan Huang

- Lijun Zhang

- Bianqin Guo

- Pu Li

- Dan Gou

13. Levels of PIVKA-II and alpha-fetoprotein in unresectable hepatocellular carcinoma compared to healthy controls and predictive values of both markers with radiological responses after loco-regional interventions

- Norhanan Hamzah

- Nur Karyatee Kassim

- Julia Omar

- Mohd Shafie Abdullah

- Yeong Yeh Lee

14. Optimizing care of HBV infection and HBV-related HCC

- Shi Yan Lee

- Benjamin Kai Yi Nah

- Jazleen Leo

- Jia Hong Koh

- Daniel Q. Huang

15. PIVKA-II combined with alpha-fetoprotein for the diagnostic value of hepatic tumors in children: a multicenter, prospective observational study

- Hongxiang Gao

- Chenjie Xie

- Jing Wang

- Ji Ma

- Shijian Liu

- Li Xie

- Yijie Zheng

- Rui Dong

- Shan Wang

- Yongjun Fang

- Yurui Wu

- Xianwei Zhang

- Xianying Lu

- Yang Li

- Weisong Li

- Qiuhui Pan

- Min Xu

- Song Gu

16. Effectiveness of PIVKA-II in the detection of hepatocellular carcinoma based on real-world clinical data

- Rentao Yu

- Zhaoxia Tan

- Xiaomei Xiang

- Yunjie Dan

- Guohong Deng

17. DNA Methylation Biomarkers as Prediction Tools for Therapeutic Response and Prognosis in Intermediate-Stage Hepatocellular Carcinoma

- Chang-Yi Lu

- Chih-Yang Hsiao

- Pey-Jey Peng

- Shao-Chang Huang

- Meng-Rong Chuang

- Hung-Ju Su

- Kai-Wen Huang

18. Characterization of Gla proteoforms and non-Gla peptides of gamma carboxylated proteins: Application to quantification of prothrombin proteoforms in human plasma

- Dilip Kumar Singh

- Abdul Basit

- Allan E. Rettie

- Nathan Alade

- Kenneth Thummel

- Bhagwat Prasad

19. Diagnosis of the Initial Stage of Hepatocellular Carcinoma: A Review

- Krishana Kumar Sharma

- Mohd. Mohsin

- Piyush Mittal

- Zeeshan Ali

- Nishat Fatma

- Prashant Upadhyay

- Ritu Gupta

- Anurag Verma

- Gajendra Kumar

20. Biomarkers vs imaging in the early detection of hepatocellular carcinoma and prognosis

- Lavinia Alice Balaceanu

21. Advances in the early diagnosis of hepatocellular carcinoma

- Weiyi Wang

- Chao Wei